IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.213
EU - Europa 5.867
AS - Asia 5.829
SA - Sud America 1.283
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 23.357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.670
SG - Singapore 2.101
IT - Italia 1.568
RU - Federazione Russa 1.472
CN - Cina 1.430
BR - Brasile 993
VN - Vietnam 868
GB - Regno Unito 856
DE - Germania 572
HK - Hong Kong 393
BD - Bangladesh 385
CA - Canada 357
UA - Ucraina 299
FR - Francia 225
SE - Svezia 207
FI - Finlandia 161
IN - India 136
MX - Messico 123
DK - Danimarca 118
AR - Argentina 110
PL - Polonia 91
TR - Turchia 80
ES - Italia 67
ID - Indonesia 65
IL - Israele 64
NL - Olanda 63
ZA - Sudafrica 59
IQ - Iraq 58
EC - Ecuador 57
IE - Irlanda 51
JP - Giappone 45
CO - Colombia 33
UZ - Uzbekistan 27
AT - Austria 25
VE - Venezuela 24
MA - Marocco 23
PK - Pakistan 23
AE - Emirati Arabi Uniti 22
PY - Paraguay 19
EG - Egitto 16
SA - Arabia Saudita 16
MY - Malesia 15
CL - Cile 14
LT - Lituania 14
JO - Giordania 12
CH - Svizzera 11
EU - Europa 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
JM - Giamaica 10
PH - Filippine 10
HN - Honduras 9
KE - Kenya 9
CR - Costa Rica 8
AU - Australia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
KZ - Kazakistan 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
NP - Nepal 6
PS - Palestinian Territory 6
BH - Bahrain 5
GY - Guiana 5
HR - Croazia 5
KG - Kirghizistan 5
LB - Libano 5
PT - Portogallo 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CG - Congo 3
GT - Guatemala 3
HU - Ungheria 3
KR - Corea 3
KW - Kuwait 3
LV - Lettonia 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
SM - San Marino 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GP - Guadalupe 2
Totale 23.320
Salva come PNG Salva come JPEG
Città #
Dallas 1.527
Singapore 1.100
Ashburn 722
San Jose 663
Beijing 603
Southend 444
Los Angeles 376
Hong Kong 359
Chicago 352
Houston 323
Chandler 314
Moscow 287
Ho Chi Minh City 265
Fairfield 252
Ann Arbor 242
New York 234
Woodbridge 226
San Mateo 200
Milan 188
Hanoi 163
Wilmington 160
Seattle 152
Rome 144
Buffalo 139
Salt Lake City 132
Cambridge 131
The Dalles 130
Falls Church 129
Santa Clara 129
Council Bluffs 126
São Paulo 117
Jacksonville 113
Dearborn 108
Ottawa 101
Boardman 95
Pisa 93
Tampa 93
Hefei 91
Lauterbourg 91
Helsinki 90
Portsmouth 79
Stevenage 79
Warsaw 78
Munich 72
Montreal 70
Brooklyn 68
Dong Ket 68
London 66
Columbus 64
Elk Grove Village 61
Mexico City 61
Orem 61
Lawrence 57
Beauharnois 56
Tel Aviv 55
Dublin 49
Denver 47
Toronto 45
Frankfurt am Main 44
Florence 43
Istanbul 43
Johannesburg 41
Tokyo 40
Chennai 39
San Diego 39
Stockholm 39
Atlanta 38
Phoenix 36
Sterling 35
Lancaster 34
Rio de Janeiro 34
Poplar 32
Amsterdam 31
Boston 29
Da Nang 28
Campinas 27
Tashkent 26
Turku 26
Guayaquil 25
Palermo 25
Haiphong 24
Naples 24
Bari 23
Genoa 23
Miami 23
Figino 22
Lappeenranta 22
Redwood City 22
Turin 22
Central District 21
Montréal 21
Mumbai 21
Nuremberg 21
Bologna 19
San Francisco 19
Belo Horizonte 18
Biên Hòa 18
Ankara 17
Baghdad 17
Dulles 17
Totale 13.508
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.581
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 697
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 454
A simple echocardiographic score to rule out cardiac amyloidosis 390
A simple echocardiographic score to rule out cardiac amyloidosis 364
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 357
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 334
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 331
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 328
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 326
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 320
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 319
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 317
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 317
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 313
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 308
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 306
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 302
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 302
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 293
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 285
Sex-related differences in chronic heart failure 281
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 271
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 270
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 269
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 262
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 262
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 261
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 260
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 259
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 259
Update sui biomarcatori nello scompenso cardiaco. 258
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 255
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 242
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 242
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 242
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 241
Cardiac magnetic resonance in patients with muscular dystrophies 241
Valvular heart disease in patients with cardiac amyloidosis 238
Role of Imaging in Cardiomyopathies 236
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 235
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 235
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 235
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 234
Cardiovascular disease and COVID-19: les liaisons dangereuses 229
Perspectives in noninvasive imaging for chronic coronary syndromes 227
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 221
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 219
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 217
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 217
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 217
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 217
Molecular autopsy of sudden cardiac death in the genomics era 217
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 214
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 213
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 212
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 207
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 206
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 205
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 201
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 201
Colchicine for the treatment of coronary artery disease 197
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 197
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 196
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 195
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 192
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 187
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 186
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 174
Troponin in non-ischaemic dilated cardiomyopathy 173
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 172
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 167
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 163
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 160
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 160
Treatment of cardiac transthyretin amyloidosis: an update 159
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 157
Partial Lipodystrophy and LMNA p.R545H Variant 156
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 156
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 151
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 135
The Barthel Index in elderly acute heart failure patients. Frailty matters 133
The unbearable underreporting of comorbidities in heart failure clinical trials 131
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 131
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 129
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 117
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 116
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 101
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 98
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 71
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 70
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 60
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype 59
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 48
A Novel SCN5A Missense Variant Associated With Familial Non-Dilated Left Ventricular Cardiomyopathy 43
Electrocardiographic abnormalities in patients with cardiomyopathies 38
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 32
Applications of Artificial Intelligence in Amyloidosis 32
Totale 23.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.130 45 54 208 67 166 214 505 970 327 915 932 727
2025/202612.105 736 1.666 1.365 1.555 1.265 769 1.052 612 762 826 810 687
2026/2027226 226 0 0 0 0 0 0 0 0 0 0 0
Totale 23.514